Larimar Therapeutics
phase dose exploration trial advances and initiation of long term open label extension trial remains on track | Larimar Therapeutics
Company
Deck Type
Sector
Industry
Deck date
November 2023
Slide
4 of 44
Related slides by other companies
Adagio Therapeutics
Investor Conference
June 2023
ongoing phase trial of with initial data planned for | Adagio Therapeutics
Immatics
Investor Presentation
November 2023
phase clinical trial to evaluate targeting | Immatics
Kymera
Investor Day
December 2021
registration strategies | Kymera
Adagio Therapeutics
Investor Presentation
May 2023
ongoing phase trial of with initial data planned for | Adagio Therapeutics
Other recent decks by Larimar Therapeutics
See all presentations (3 decks)
Results
November 2022
Investor Presentation
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights